216 related articles for article (PubMed ID: 34523690)
1. Ginsenoside Rg1 ameliorates aging‑induced liver fibrosis by inhibiting the NOX4/NLRP3 inflammasome in SAMP8 mice.
Li Y; Zhang D; Li L; Han Y; Dong X; Yang L; Li X; Li W; Li W
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34523690
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg1 ameliorates glomerular fibrosis during kidney aging by inhibiting NOX4 and NLRP3 inflammasome activation in SAMP8 mice.
Shen X; Dong X; Han Y; Li Y; Ding S; Zhang H; Sun Z; Yin Y; Li W; Li W
Int Immunopharmacol; 2020 Feb; 82():106339. PubMed ID: 32114413
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-(1-7) Improves Liver Fibrosis by Regulating the NLRP3 Inflammasome via Redox Balance Modulation.
Cai SM; Yang RQ; Li Y; Ning ZW; Zhang LL; Zhou GS; Luo W; Li DH; Chen Y; Pan MX; Li X
Antioxid Redox Signal; 2016 May; 24(14):795-812. PubMed ID: 26728324
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg1 alleviates acute liver injury through the induction of autophagy and suppressing NF-κB/NLRP3 inflammasome signaling pathway.
Zhao J; He B; Zhang S; Huang W; Li X
Int J Med Sci; 2021; 18(6):1382-1389. PubMed ID: 33628094
[No Abstract] [Full Text] [Related]
5. Ginsenoside Rg1 Protects against Non-alcoholic Fatty Liver Disease by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammasome Activation.
Xu Y; Yang C; Zhang S; Li J; Xiao Q; Huang W
Biol Pharm Bull; 2018 Nov; 41(11):1638-1644. PubMed ID: 30135326
[TBL] [Abstract][Full Text] [Related]
6. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice.
Wu M; Han W; Song S; Du Y; Liu C; Chen N; Wu H; Shi Y; Duan H
Mol Cell Endocrinol; 2018 Dec; 478():115-125. PubMed ID: 30098377
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rg1 protects mice against streptozotocin-induced type 1 diabetic by modulating the NLRP3 and Keap1/Nrf2/HO-1 pathways.
Gao Y; Li J; Chu S; Zhang Z; Chen N; Li L; Zhang L
Eur J Pharmacol; 2020 Jan; 866():172801. PubMed ID: 31738935
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin (1-7) inhibits arecoline-induced migration and collagen synthesis in human oral myofibroblasts via inhibiting NLRP3 inflammasome activation.
You Y; Huang Y; Wang D; Li Y; Wang G; Jin S; Zhu X; Wu B; Du X; Li X
J Cell Physiol; 2019 Apr; 234(4):4668-4680. PubMed ID: 30246378
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg1 protects against H2O2‑induced neuronal damage due to inhibition of the NLRP1 inflammasome signalling pathway in hippocampal neurons in vitro.
Xu TZ; Shen XY; Sun LL; Chen YL; Zhang BQ; Huang DK; Li WZ
Int J Mol Med; 2019 Feb; 43(2):717-726. PubMed ID: 30535505
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria-targeted reactive oxygen species blockor SS-31 blocks hepatic stellate cell activation and alleviates hepatic fibrosis by regulating NLRP3 inflammasomes.
Liu L; Wei Y; Xie N; Cai H; Lin Y
Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):183-188. PubMed ID: 38430023
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin(1-7) attenuated Angiotensin II-induced hepatocyte EMT by inhibiting NOX-derived H2O2-activated NLRP3 inflammasome/IL-1β/Smad circuit.
Zhang LL; Huang S; Ma XX; Zhang WY; Wang D; Jin SY; Zhang YP; Li Y; Li X
Free Radic Biol Med; 2016 Aug; 97():531-543. PubMed ID: 27445100
[TBL] [Abstract][Full Text] [Related]
12. Ursolic acid reverses liver fibrosis by inhibiting NOX4/NLRP3 inflammasome pathways and bacterial dysbiosis.
Nie Y; Liu Q; Zhang W; Wan Y; Huang C; Zhu X
Gut Microbes; 2021; 13(1):1972746. PubMed ID: 34530693
[TBL] [Abstract][Full Text] [Related]
13. Paricalcitol attenuates TGF-β1-induced phenotype transition of human peritoneal mesothelial cells (HPMCs) via modulation of oxidative stress and NLRP3 inflammasome.
Ko J; Kang HJ; Kim DA; Ryu ES; Yu M; Lee H; Lee HK; Ryu HM; Park SH; Kim YL; Kang DH
FASEB J; 2019 Feb; 33(2):3035-3050. PubMed ID: 30354670
[TBL] [Abstract][Full Text] [Related]
14. Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice.
Yu Y; Chen D; Zhao Y; Zhu J; Dong X
Int J Immunopathol Pharmacol; 2021; 35():20587384211036819. PubMed ID: 34399601
[TBL] [Abstract][Full Text] [Related]
15. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
[TBL] [Abstract][Full Text] [Related]
16. The protective effects of orexin a against high glucose-induced activation of NLRP3 inflammasome in human vascular endothelial cells.
Zhang C; Abdukerim M; Abilailieti M; Tang L; Ling Y; Pan S
Arch Biochem Biophys; 2019 Sep; 672():108052. PubMed ID: 31351069
[TBL] [Abstract][Full Text] [Related]
17. Oxymatrine attenuates oxidized low‑density lipoprotein‑induced HUVEC injury by inhibiting NLRP3 inflammasome‑mediated pyroptosis via the activation of the SIRT1/Nrf2 signaling pathway.
Jin X; Fu W; Zhou J; Shuai N; Yang Y; Wang B
Int J Mol Med; 2021 Oct; 48(4):. PubMed ID: 34368883
[TBL] [Abstract][Full Text] [Related]
18. Hepatoprotection by Ginsenoside Rg1 in alcoholic liver disease.
Yang C; He X; Zhao J; Huang W
Int Immunopharmacol; 2021 Mar; 92():107327. PubMed ID: 33412392
[TBL] [Abstract][Full Text] [Related]
19. A novel danshensu derivative ameliorates experimental colitis by modulating NADPH oxidase 4-dependent NLRP3 inflammasome activation.
Pan LL; Ren Z; Liu Y; Zhao Y; Li H; Pan X; Fang X; Liang W; Wang Y; Yang J; Sun J
J Cell Mol Med; 2020 Nov; 24(22):12955-12969. PubMed ID: 32945118
[TBL] [Abstract][Full Text] [Related]
20. Autophagy Attenuates Angiotensin II-Induced Pulmonary Fibrosis by Inhibiting Redox Imbalance-Mediated NOD-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation.
Meng Y; Pan M; Zheng B; Chen Y; Li W; Yang Q; Zheng Z; Sun N; Zhang Y; Li X
Antioxid Redox Signal; 2019 Feb; 30(4):520-541. PubMed ID: 29486589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
